Log In
Print this Print this

ciprofloxacin (Cipro XR)

  Manage Alerts
Collapse Summary General Information
Company Bayer AG
DescriptionExtended-release formulation of ciprofloxacin, a fluoroquinolone
Molecular Target DNA gyrase
Mechanism of ActionProkaryotic replication inhibitor
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationBacterial infection
Indication DetailsTreat and prevent bacterial infection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today